B. Metzler seel. Sohn & Co. AG Acquires New Position in Ventas, Inc. $VTR

Key Points

• B. Metzler seel. Sohn & Co. AG initiated a Ventas position by purchasing 22,400 shares valued at approximately $1.99 million. Institutional investors collectively own 94.18% of the healthcare REIT.
• Ventas reported quarterly earnings of $0.97 per share, exceeding estimates by $0.01, while revenue rose 21.7% year over year to $1.73 billion.
• Analysts maintain a favorable outlook, with a consensus “Moderate Buy” rating and an average price target of $98, compared with the stock’s reported price of $93.32.

B. Metzler seel. Sohn & Co. AG bought a new position in Ventas, Inc. (NYSE:VTR - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 22,400 shares of the real estate investment trust's stock, valued at approximately $1,989,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. BlackRock Inc. bought a new position in shares of Ventas in the second quarter worth approximately $4,953,439,000. Capital World Investors purchased a new position in shares of Ventas during the 4th quarter valued at $594,116,000. Norges Bank purchased a new position in shares of Ventas during the 4th quarter valued at $474,571,000. Deutsche Bank AG bought a new position in Ventas in the 2nd quarter worth $451,822,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in Ventas by 32,509.3% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 4,648,776 shares of the real estate investment trust's stock worth $359,722,000 after buying an additional 4,634,520 shares during the period. Institutional investors own 94.18% of the company's stock.

Ventas Stock Up 0.7%

Shares of VTR stock opened at $93.32 on Friday. The stock has a market cap of $47.87 billion, a P/E ratio of 172.81, a PEG ratio of 2.15 and a beta of 0.69. Ventas, Inc. has a 52 week low of $66.38 and a 52 week high of $101.60. The company has a quick ratio of 0.44, a current ratio of 0.44 and a debt-to-equity ratio of 0.86. The company's fifty day simple moving average is $91.36 and its two-hundred day simple moving average is $87.08.

Ventas (NYSE:VTR - Get Free Report) last issued its quarterly earnings data on Wednesday, July 29th. The real estate investment trust reported $0.97 earnings per share for the quarter, beating analysts' consensus estimates of $0.96 by $0.01. Ventas had a return on equity of 1.99% and a net margin of 4.08%.The firm had revenue of $1.73 billion during the quarter, compared to analyst estimates of $1.68 billion. During the same quarter last year, the business posted $0.87 earnings per share. The business's quarterly revenue was up 21.7% compared to the same quarter last year. Analysts predict that Ventas, Inc. will post 3.89 EPS for the current fiscal year.

Analyst Ratings Changes

VTR has been the subject of a number of analyst reports. Weiss Ratings upgraded Ventas from a "hold (c+)" rating to a "buy (b-)" rating in a research note on Tuesday, July 21st. Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating and issued a $100.00 price objective on shares of Ventas in a research note on Tuesday, June 16th. Cantor Fitzgerald increased their target price on Ventas from $97.00 to $102.00 and gave the stock an "overweight" rating in a research report on Friday, July 31st. Raymond James Financial initiated coverage on Ventas in a research note on Tuesday, June 16th. They set an "outperform" rating and a $94.00 target price on the stock. Finally, BMO Capital Markets boosted their price target on Ventas from $105.00 to $107.00 and gave the stock an "outperform" rating in a report on Tuesday, August 11th. Fifteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Ventas has a consensus rating of "Moderate Buy" and a consensus target price of $98.00.

Insider Buying and Selling

In other news, Director Michael J. Embler purchased 2,500 shares of the business's stock in a transaction on Wednesday, June 3rd. The stock was acquired at an average price of $78.81 per share, for a total transaction of $197,025.00. Following the acquisition, the director directly owned 19,202 shares of the company's stock, valued at $1,513,309.62. This represents a 14.97% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.53% of the company's stock.

About Ventas

Ventas, Inc NYSE: VTR is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas' business model combines property ownership with active asset management and capital markets activity.

Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source